Market Place
Sourcing Support
All News #Library
Biotech
Guardant Hits The Road With Colon Cancer Blood Test
05 Mar 2026 //
FIERCE BIOTECH
Guardant Health Gets FDA Nod For Guardant360 CDx With BRAFTOVI
22 Jan 2026 //
BUSINESSWIRE
Guardant Health Launches Shield Blood Test For Colorectal Cancer
08 Jan 2026 //
BUSINESSWIRE
Guardant Health, Policlinico Gemelli Launch Liquid Biopsy
09 Dec 2025 //
PHARMIWEB
Guardant Health Expands Reveal Test For Late-Stage Therapy
10 Nov 2025 //
BUSINESS WIRE
Guardant Reveal Blood Test Validated For Chemotherapy Response
06 Nov 2025 //
BUSINESS WIRE
Guardant Health, ZephyrAI Partner To Unlock Drug Response
27 Oct 2025 //
BUSINESS WIRE
FDA Approves Guardant360® Cdx For Eli Lilly`s Inluriyo
29 Sep 2025 //
BUSINESSWIRE
Guardant Health to Present at Morgan Stanley Global Confernece
26 Aug 2025 //
BUSINESSWIRE
Guardant360-Guided Breast Cancer Therapy Swaps Boost Survival
03 Jun 2025 //
FIERCE BIOTECH
SERENA-6 Trial Shows Guardant360 CDx Test Value in Breast Cancer
02 Jun 2025 //
BUSINESSWIRE
Guardant Health, Collaborators to Present 19 Studies at 2025 ASCO
22 May 2025 //
BUSINESSWIRE
Guardant Health, Pfizer collaborate on Cancer Therapies
24 Apr 2025 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.